Best Price*  ₹ 350.40
MRP ₹438.00
(Inclusive of all taxes) *31 Tablet(s) in a Strip * Mkt: Sun Pharmaceutical Industries Ltd * Country of Origin: India * Delivery charges if applicable will be applied at checkout

Check Availability & Expiry

PINCODE:


INTRODUCTION

IDROFOS contains Ibandronic acid which belongs to a group of medicines called bisphosphonates. It is used to treat and prevent osteoporosis in women after menopause. It helps to increase bone mass and reduce the chance of having a spinal fracture. Postmenopausal osteoporosis develops after menopause, when estrogen levels drop precipitously. These changes lead to bone loss, usually in the trabecular (spongy) bone inside the hard cortical bone. Thinning and weakening of the bones is common in women after the menopause.

IDROFOS reduces the amount of calcium leaving the bone and make the bone stronger by binding to the bone. It slows down the rate of bone loss and increases the bone density, thus reducing the risk of broken bones and fractures. Always take this medicine as directed your Doctor. Before taking this medicine, inform your doctor if you have kidney problems or low calcium levels. It is not for children and adolescents below 18 years of age. The common side effects are diarrhoea, headache, stomach or back pain.

USES OF IDROFOS

  • Treats postmenopausal osteoporosis

HOW IDROFOS WORKS

IDROFOS reduces the amount of calcium leaving the bone and make the bone stronger by binding to the bone. It slows down the rate of bone loss and increases the bone density, thus reducing the risk of broken bones and fractures.

DIRECTIONS FOR USE

Always take this IDROFOS as directed your doctor. Swallow it as a whole. Do not chew, crush or break the medicine. It must be taken on empty stomach.

SIDE EFFECTS OF IDROFOS

COMMON

  • headache
  • heartburn
  • back pain
  • stomach pain
  • pain in your arms and legs
  • diarrhea
  • muscle pain
  • flu-like symptoms

RARE

  • itching
  • swelling of face, lips, tongue and throat
  • difficulty breathing
  • persistent eye pain and inflammation
  • weakness
  • discomfort in thigh, hip or groin

HOW TO MANAGE SIDE EFFECTS

Headache:

Apply hot or cold-water bag on your head. Take rest in a quiet and dark room. Drink tea or coffee.

Diarrhea:

Drink plenty of fluids to avoid dehydration. ORS should be used to prevent dehydration.

Heartburn:

Avoid late night eating. Do not exercise right after meals.

WARNING & PRECAUTIONS

PREGNANCY

IDROFOS is not recommended for use in pregnant women unless necessary. Discuss the risks and benefits with your doctor.

BREASTFEEDING

IDROFOS is not recommended for use in breastfeeding women unless necessary. Discuss the risks and benefits with your doctor.

KIDNEY

IDROFOS should be used with caution in patients suffering from active kidney diseases. Consult your doctor for advice.

ALLERGY

Do not take if you are allergic (hypersensitive) to Ibandronic acid or any ingredients of this medicine.

OTHERS

Tell your doctor if you had or have a condition such as:

  • problems with your oesophagus
  • low blood calcium
  • vitamin D deficiency
  • swallowing or digestive problems

INTERACTIONS

Inform your doctor if you are taking or have recently taken any other medicines, including medicines obtained without a prescription or the following:

  • supplements containing calcium, magnesium, iron or aluminium
  • ibuprofen, diclofenac sodium and naproxen
  • aspirin

SYNOPSIS

Drug :   Ibandronic acid (Ibandronate)
Pharmacological Category :   Bisphosphonate derivative
Therapeutic Indication :   postmenopausal osteoporosis
Dosage Forms :   Tablet, Injection

MORE INFORMATION

Store below 20-25°C and keep out of reach of children.

FAQs ABOUT IDROFOS

How does IDROFOS work?

It works by increasing the density of the bones which prevent osteoporosis.  

Is IDROFOS safe?

It is safe if used in the dose and duration instructed by your doctor. Use as directed and do not skip any dose.

What is IDROFOS used for?

It belongs to a class of medicines called bisphosphonates that prevents abnormal breakdown of the bones. It is used to treat and prevent osteoporosis in women after menopause.

REFERENCES

1. KD Tripathi MD. Drugs affecting calcium balance. Essentials of Medical Pharmacology 7th ed. New Delhi, May 2013. Page - 243.

2. Peter A. Friedman. Agents affecting mineral ion Homeostatsis and Bone turnover.  Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. Page - 1296.

3. Young Ho Lee and Gwan Gyu Song. Efficacy and Safety of Monthly 150 mg Oral Ibandronate in Women with Postmenopausal Osteoporosis: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Sep 13, 2011; [Accessed Dec 4, 2020] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3192207/

4. Zentiva, One Onslow Street (UK). Electronic Medicines Compendium (EMC); [Revised Feb 2014] [Accessed Dec 4, 2020] https://www.medicines.org.uk/emc/files/pil.2943.pdf

5. Boniva, Genentech, Inc. 2003. U.S. Food & Drug Administration; [Revised March 2015] [Accessed Dec 4, 2020] https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021455s019lbl.pdf

USEFUL DIAGNOSTIC TESTS

  • Calcium

PRODUCT DETAILS

    Net Qty
    1
    Item Weight
    20
    Ingredient
    IBANDRONIC ACID(IBANDRONATE) 150MG+CALCIUM 225MG+CHOLECALCIFEROL(VIT D3) 800 IU
    Hsn Code
    30049091
DISCLAIMER

The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.

Idrofos Kit 31'S

Idrofos Kit 31'S Mkt: Sun Pharmaceutical Industries Ltd

M.R.P.: Rs.438.00
Copyright© 2021. All Rights Reserved.